AbCellera Biologics Inc.

NASDAQ:ABCL

2.72 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182001
Operating Activities:
Net Income -146.398158.519153.464118.918-2.2110.3090
Depreciation & Amortization 30.89433.10217.255.2711.8470.9180
Deferred Income Tax 1.96-2.114-2.0182.098000
Stock Based Compensation 64.18349.48130.6468.3970.890.6150
Change In Working Capital 13.22529.82541.672-116.7011.9731.9110
Accounts Receivables -45.933-22.715-37.386-5.467-1.803-0.4770
Inventory 18.253040.919-134.348-0.15-0.8980
Accounts Payables -15.1041.0661.46.6010.150.180
Other Working Capital 56.00951.47436.73916.5133.7763.1060
Other Non Cash Items -7.7418.5473.574.7070.194-0.1880
Operating Cash Flow -43.877277.36244.58422.692.6943.5650
Investing Activities:
Investments In Property Plant And Equipment -77.507-72.66-58.452-14.673-3.997-5.3070
Acquisitions Net -13.69-25.679-41.78-106.89000
Purchases Of Investments -1,066.159-781.351-292.244-19.247000
Sales Maturities Of Investments 910.937510.63127.60819.247000
Other Investing Activites 25.31116.43432.6211.783-1.78300
Investing Cash Flow -221.108-352.625-332.247-119.78-5.78-5.3070
Financing Activities:
Debt Repayment -11.59-2.755-1.823-19.942-0.399-0.8990
Common Stock Issued 004.615522.840.0142.6120
Common Stock Repurchased 0000-0.01100
Dividends Paid 0000000
Other Financing Activities -1.234-4.383-6.678180.7550.60510.4730
Financing Cash Flow 10.356-1.628-3.886683.6530.19512.1860
Other Information:
Effect Of Forex Changes On Cash 0.589-9.599-1.4250000
Net Change In Cash -254.04-86.492-92.974586.563-2.89110.4440
Cash At End Of Period 160.61414.65501.142594.1167.55310.4440